eart failure (HF) is the final common stage of various heart diseases and has a significant effect on quality of life and prognosis. The heart relies almost exclusively on an aerobic oxidative substrate for the generation of ATP, which is required to maintain its contractile function. The balance between oxygen demand and supply is disturbed in many disease processes. The progression to HF is associated with a gradual decline in the activity of mitochondrial respiratory pathways, leading to diminished capacity for ATP production. 1 Cardiac metabolic alterations could be either adaptive or maladaptive. Furthermore, the specific etiology of HF may be of importance in the process. Cardiac metabolic alterations may correlate with the degree of left ventricular (LV) dysfunction, symptoms of HF, prognosis and the response to medical treatments. [1][2][3] For a better understanding of the pathophysiology of cardiac metabolic alterations, it is important to measure myocardial oxygen consumption (MV • O2). The clearance kinetics of 11 C-acetate, measured by positron emission tomography (PET), can be used to measure tricarboxylic acid cycle flux and thus enable noninvasive quantification of myocardial oxidative metabolism at both the global and regional levels. [2][3][4][5][6][7] The level of myocardial oxidative metabolism with failing LV systolic function has been reported to be comparable to or lower than normal LV function. 8,9 Dyssynchrony is a predictor of poor outcome and may be associated with heterogeneity of myocardial oxidative metabolism in patients with HF. Previous studies have only evaluated rather small populations because of limited availability, and clinical significance has not been clarified in broader populations with HF. In addition, the differences between ischemic (ICM) and idiopathic dilated cardiomyopathy (DCM) have not been fully investigated.Accordingly, the aims of this study were to evaluate myocardial oxidative metabolism by using 11 C-acetate PET in a cohort and to compare the oxidative alterations with clinical variables, such as symptoms of HF, left bundle branch block (LBBB) and echocardiographic parameters, in patients with ICM and DCM.
Methods
Study PopulationThe study population comprised 100 consecutive pa- Yuji Kuge, PhD**; Hiroyuki Tsutsui, MD*; Nagara Tamaki, MD** Background The 11 C-acetate positron emission tomography can estimate myocardial oxidative metabolism, but previous studies have only evaluated small populations and the difference between ischemic (ICM) and idiopathic dilated cardiomyopathy (DCM) has not been fully investigated. The present aims were to evaluate global and regional myocardial oxidative metabolism in a well-characterized, large population with left ventricular (LV) dysfunction in order to clarify the metabolic differences between ICM and DCM.
Methods and ResultsSeventy-eight patients with ejection fraction (EF) ≤50% (33 ICM; 45 DCM) were compared with 14 healthy controls. Myocardial oxidative metabolism was estimated with a clearance rate constant (Kmono...